Medline Overview
Latest P/E ratio for Medline: 32.46 — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow32.46
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
Medline's p/e ratio stands at 32.46. That is below the sector sector average of 44.85. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.
Medline sits lower the its sector benchmark (44.85) with a P/E ratio of 32.46. That is roughly 27.6% below the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.
Whether 32.46 is attractive depends on Medline's earnings outlook, competitive position, and how peers are valued. Investors typically ask: is growth accelerating, are margins stable, and is the multiple expanding or compressing over time? The history and comparison charts below are built for those checks.
The history chart shows how Medline's P/E ratio evolved across reporting periods, while the comparison chart places MDLN next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.
